ZEMFIRZA
AstraZeneca AB
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87647069 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Wm. Charles Saunders |
| Law Office Assigned | N60 |
| Employee Name | RIEPEL, CHRISTINA MAXI |
Timeline
| 2017-10-16 | Application Filed |
| 2018-01-30 | Published for Opposition |
| 2018-03-27 | Location: INTENT TO USE SECTION |
| 2018-10-29 | Abandon |
| 2018-10-29 | Status: Dead/Abandoned |
| 2018-10-29 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  AstraZeneca AB |
| Entity Statement | aktiebolag (ab) |
| Address | Vastra Malarehamnen 9 Södertälje SE SE-15185 |
| Legal Entity Type | |
| Legal Entity State | SE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-10-19 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-10-25 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-11-29 | 3 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2017-12-01 | 4 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2017-12-01 | 5 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2017-12-01 | 6 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2017-12-01 | 7 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-12-01 | 8 CNSA P: |
| ASSIGNED TO LIE | 2017-12-15 | 9 ALIE A:Allowance for Publication |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-01-10 | 10 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-01-30 | 11 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-01-30 | 12 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-03-27 | 13 NOAM E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2018-10-29 | 14 ABN6 S: |
| ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2018-10-29 | 15 MAB6 O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ZEMFIRZA 87647069 not registered Dead/Abandoned |
AstraZeneca AB 2017-10-16 |
 ZEMFIRZA 77494831 3812522 Dead/Cancelled |
AstraZeneca AB 2008-06-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 